MXC: $0.073
Why Invest

Welcome to the Investor Centre. This section is dedicated to the latest company information to our existing and prospective investors. This includes ASX announcements, financial reports, and other important updates. Investors can also access FAQs and view the latest share price information here.

MGC Pharmaceuticals trades on the Australian Securities Exchange (ASX) under the ticker code MXC.

Welcome to the Investor Centre

Founded in 2014 by experts in the Medical Cannabis field with the intention of capitalising on the emerging global Medical Cannabis industry, founders Nativ Segev and Roby Zomer bring a combination of over 10 years in the Medical Cannabis and the BioTech industry. MGC Pharma was created to become a leading BioPharma company based on Medical Cannabis with operations spanning all aspects of the value chain, from cultivation, manufacturing and distribution of products in a global market.

Today, MGC Pharma has operations spanning Europe and Australia. It has cultivated and harvested crops in its growing facilities in the Czech Republic and Slovenia and is manufacturing active pharmaceutical ingredients (APIs) at its European GMP extraction facility. The Company has also developed a CBD cosmetics range that is available for purchase throughout Europe and online via the Company’s eShop www.mgcderma.com